Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion
复制标题
DOI：
10.1016/j.fertnstert.2019.09.013
复制
发表时间：
2019-12-01
影响因子：
6.7
通讯作者：
Stovall, Dale
中科院分区：
文献类型：
--
作者：
Penzias, Alan;Bendikson, Kristin;Stovall, Dale
准备接受性腺毒性药物治疗、放射治疗或性腺切除术的患者，应及时获得关于医源性不孕症生育保留方案的咨询。生育力保存可以通过设计和装备的综合方案来最好地提供，以应对这些患者面临的独特挑战。本文件以类似的名称取代了最后一次发布于2013年的文件。(C)2019年，美国生殖医学会。
Patients preparing to undergo gonadotoxic medical therapy, radiation therapy, or gonadectomy should be provided with prompt counseling regarding available options for fertility preservation for iatrogenic infertility. Fertility preservation can best be provided by comprehensive programs designed and equipped to confront the unique challenges facing these patients. This document replaces the document with a similar name, last published in 2013. (C) 2019 by American Society for Reproductive Medicine.